United Capital Financial Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $263K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $390K | Sell |
|
|||||
|
2024
Q1 | $537K | Buy |
|
|||||
|
2023
Q4 | $280K | Buy |
|
|||||
|
2023
Q3 | $237K | Buy |
|
|||||
|
2023
Q2 | $230K | Sell |
|
|||||
|
2023
Q1 | $288K | Sell |
|
|||||
|
2022
Q4 | $516K | Sell |
|
|||||
|
2022
Q3 | $1.2M | Sell |
|
|||||
|
2022
Q2 | $1.18M | Sell |
|
|||||
|
2022
Q1 | $1.13M | Sell |
|
|||||
|
2021
Q4 | $1.31M | Sell |
|
|||||
|
2021
Q3 | $1.18M | Buy |
|
|||||
|
2021
Q2 | $1.27M | Sell |
|
|||||
|
2021
Q1 | $1.79M | Buy |
|
|||||
|
2020
Q4 | $813K | Sell |
|
|||||
|
2020
Q3 | $1.38M | Buy |
|
|||||
|
2020
Q2 | $670K | Buy |
|
|||||
|
2020
Q1 | $439K | Buy |
|
|||||
|
2019
Q4 | $317K | Buy |
|